Opinion: 2022 could be the year for pharmaceutical marijuana
Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market…
News March 21Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market…
News March 21Auxly Cannabis finalized an investment from Imperial Brands worth 123 million Canadian dollars ($92 million), one of the…
News September 26North American cannabis companies have raised nearly $3.3 billion so far this year, outpacing the record funding levels…
News March 14Two weeks after announcing a major move into the marijuana market with an investment of $1.8 billion in…
News December 20